Table 2.
Comparison of the clinical characteristics of patients with and without nonalcoholic steatohepatitis (mean ± SD)
| Variable | NASH n =28 | Non-NASH n = 22 | P value |
| Age (yr) | 41.8 ± 11.2 | 40.9 ± 15.3 | 0.80 |
| Weight (kg) | 77.0 ± 10.3 | 81.8 ± 14.1 | 0.17 |
| Height (cm) | 167.1 ± 9.2 | 168.2 ± 9.9 | 0.68 |
| BMI (kg/m²) | 0.153 | ||
| < 25 | 23.63 ± 0.7 | 23.97 ± 1.1 | |
| 25-29.9 | 28.09 ± 1.4 | 27.25 ± 1.3 | |
| ≥ 30 | 31.25 ± 1.5 | 34.25 ± 4.0 | |
| ALT (U/mL) | 89.7 ± 40.5 | 66.7 ± 24.3 | 0.02 |
| AST (U/mL) | 51.7 ± 20.4 | 42.4 ± 15.3 | 0.08 |
| AST/ALT ratio | 0.6 ± 0.1 | 0.6 ± 0.2 | 0.28 |
| ALP (mg/dL) | 217.3 ± 88.3 | 198.5 ± 54.3 | 0.38 |
| Albumin (mg/dL) | 4.5 ± 0.4 | 4.3 ± 0.5 | 0.18 |
| FBS (mg/dL) | 108.5 ± 27.3 | 95.3 ± 11 | 0.03 |
| TG (mg/dL) | 238.7 ± 110.8 | 173.6 ± 85.7 | 0.02 |
| Cholesterol (g/dL) | 206.7 ± 39.7 | 195.3 ± 32.9 | 0.28 |
| HDL (mg/dL) | 44.8 ± 10.3 | 47.9 ± 10.6 | 0.31 |
| LDL (mg/dL) | 117.7 ± 29.5 | 121.7 ± 49.9 | 0.72 |
| IgA (mg/dL) | 351.3 ± 125.9 | 289.6 ± 80.4 | 0.052 |
ALT: Alanine aminotransferase; AST: Aspartate aminotransferase; ALP: Alkaline phosphatase; HDL: High-density lipoprotein; HDL: High-density lipoprotein; IgA: Immunoglobulin A.